title: Serotonin syndrome resulting from drug interactions.
abstract: We describe six patients diagnosed with serotonin syndrome after exposure to drugs with serotonergic activity. Drug interactions occurred as a result of a combination of tricyclic antidepressants, selective serotonin reuptake inhibitors, selective noradrenaline reuptake inhibitors or monoamine oxidase inhibitors. Management included supportive care and the use of non-specific serotonin antagonists (cyproheptadine, benzodiazepines and chlorpromazine). All patients made uneventful recoveries.
authors.affiliation: Department of Emergency Medicine, Prince of Wales Hospital, NSW.
authors.forename: B S
authors.initials: BS
authors.lastname: Chan
authors.forename: A
authors.initials: A
authors.lastname: Graudins
authors.forename: I M
authors.initials: IM
authors.lastname: Whyte
authors.forename: A H
authors.initials: AH
authors.lastname: Dawson
authors.forename: G
authors.initials: G
authors.lastname: Braitberg
authors.forename: G G
authors.initials: GG
authors.lastname: Duggin
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects*; D012702:Serotonin Antagonists / Q000627:therapeutic use; D020230:Serotonin Syndrome / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
chemical_list: D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors